Platelet Rich Plasma injections in early osteoarthritis knee.

Comparing 4ml vs 8ml Intraarticular PRP Injection for early OA knee:A Prospective Randomized double blinded Control Trial.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023403

Enrollment

Registered

2020-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: Injecting pletelet rich plasma in affected knee joints: knee joints in first group will be injected with 4 ml pletelet rich plasma. A single injection will be given in each joint. patie

Eligibility

Inclusion criteria

Inclusion criteria: Primary osteoarthritis

Exclusion criteria

Exclusion criteria: Osteoarthritis secondary to other diseases

Design outcomes

Primary

Measure	Time frame
reduction in pain using WOMAC Scores and VAS ScoresTimepoint: baseline , 3 weeks , 24 weeks	—

Secondary

Measure	Time frame
Patient satisfaction and adverse effectsTimepoint: 20 weeks	—

Countries

India

Contacts

Public ContactDr Sandeep Patel

Pgimer Chandigarh

shivamgahlaut1988@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026